Bosutinib
99%
- Product Code: 74001
CAS:
380843-75-4
| Molecular Weight: | 530.45 g./mol | Molecular Formula: | C₂₆H₂₉Cl₂N₅O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00057361 | |
| Melting Point: | 116-120 °C | Boiling Point: | |
| Density: | 1.36g/mL | Storage Condition: | room temperature, dry |
Product Description:
Bosutinib is primarily used in the treatment of chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow. It works by inhibiting specific tyrosine kinases, which are enzymes that promote the growth of cancer cells. This targeted therapy helps to slow down or stop the progression of CML, particularly in patients who have developed resistance to other treatments. Bosutinib is often prescribed for patients in the chronic, accelerated, or blast phase of CML. It is taken orally, usually once daily, and is part of a broader strategy to manage and control the disease. Regular monitoring is required to assess its effectiveness and manage potential side effects.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | off-white to yellow to light brown powder or solid |
| PURITY | 99-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿520.00 |
+
-
|
| 0.100 | 10-20 days | ฿2,520.00 |
+
-
|
| 1.000 | 10-20 days | ฿8,500.00 |
+
-
|
| 5.000 | 10-20 days | ฿24,600.00 |
+
-
|
Bosutinib
Bosutinib is primarily used in the treatment of chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow. It works by inhibiting specific tyrosine kinases, which are enzymes that promote the growth of cancer cells. This targeted therapy helps to slow down or stop the progression of CML, particularly in patients who have developed resistance to other treatments. Bosutinib is often prescribed for patients in the chronic, accelerated, or blast phase of CML. It is taken orally, usually once daily, and is part of a broader strategy to manage and control the disease. Regular monitoring is required to assess its effectiveness and manage potential side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :